Easy and convenient weekly injections at home
Retatrutide Retatrutide is a triple agonist (GIP/GLP-1/glucagon receptor) currently in late-stage clinical trials that has shown remarkable weight loss results of up to 24% in Phase 2 studies
Starting can be 1-2mg once weekly, with gradual increases every 4 weeks up to 12mg once weekly, titration is done to reduce GI side effects like nausea and vomiting
You shouldnt take Wegovy if you: Before taking Wegovy, you should always discuss your individual and family health history with your prescriber and tell them about any medications youre taking
(6) M H Rasmussen, J Frystyk, T Andersen, L Breum, et al (1994) The impact of obesity, fat distribution, and energy restriction on insulin-like growth factor-1 (IGF-1), IGF-binding protein-3, insulin, and growth hormone Metabolism, 1994 Mar, Volume 43 (Issue 3), Pages 315-9